| abstract |
Treating a joint injury to a subject eligible for treatment, comprising administering to the subject an amount of an antagonist, such as a CD20 antibody, that binds to a B-cell surface marker, in an amount effective to slow the progression of joint damage as measured by radiography Is provided. Products useful for such methods are also provided. |